糖尿病与结核病的双重罹患及联合防控

王嘉艺 王学梅 吴静

引用本文: 王嘉艺, 王学梅, 吴静. 糖尿病与结核病的双重罹患及联合防控[J]. 疾病监测, 2016, 31(10): 859-863. DOI: 10.3784/j.issn.1003-9961.2016.10.014 shu
Citation:  WANG Jia-yi, WANG Xue-mei and WU Jing. Co-prevalence of diabetes mellitus and tuberculosis and joint management of the diseases[J]. Disease Surveillance, 2016, 31(10): 859-863. DOI: 10.3784/j.issn.1003-9961.2016.10.014 shu

糖尿病与结核病的双重罹患及联合防控

摘要: 糖尿病与结核病均给人类健康带来严重的威胁,一些低-中等收入国家有着两种疾病共存的高疾病负担。随着两者之间的关系逐渐被认识,对于两种疾病双重罹患的联合防控将成为另一项全世界关注的重大公共卫生挑战。本研究从糖尿病与结核病的流行现状、双重罹患的相互关系以及联合防控的策略措施等方面的研究进展进行了综述。

English

    1. [1]

      LnnrothK,RoglicG,HarriesAD.Improvingtuberculosispreventionandcarethroughaddressingtheglobaldiabetesepidemic:fromevidencetopolicyandpractice[J].LancetDiabetesEndocrinol,2014,2(9):730-739.

    2. [2]

      WHO.Globaltuberculosisreport2015[R].20thed.Geneva:WorldHealthOrganization,2015.

    3. [3]

      StevensonCR,CritchleyJA,ForouhiNG,etal.Diabetesandtheriskoftuberculosis:aneglectedthreattopublichealth[J].ChronicIlln,2007,3(3):228-245.

    4. [4]

      JeonCY,MurrayMB.Diabetesmellitusincreasestheriskofactivetuberculosis:asystematicreviewof13observationalstudies[J].PLoSMed,2008,5(7):e152.

    5. [5]

      YoungF,WottonCJ,CritchleyJA,etal.Increasedriskoftuberculosisdiseaseinpeoplewithdiabetesmellitus:record-linkagestudyinaUKpopulation[J].JEpidemiolCommunityHealth,2012,66(6):519-523.

    6. [6]

      DooleyKE,TangT,GolubJE,etal.Impactofdiabetesmellitusontreatmentoutcomesofpatientswithactivetuberculosis[J].AmJTropMedHyg,2009,80(4):634-639.

    7. [7]

      BakerMA,HarriesAD,JeonCY,etal.Theimpactofdiabetesontuberculosistreatmentoutcomes:asystematicreview[J].BMCMed,2011,9(1):81.

    8. [8]

      Jimnez-CoronaME,Cruz-HervertLP,Garca-GarcaL,etal.Associationofdiabetesandtuberculosis:impactontreatmentandpost-treatmentoutcomes[J].Thorax,2013,68(3):214-220.

    9. [9]

      PimazoniA.Theimpactoftuberculosistreatmentonglycaemiccontrolandthesignificantresponsetorosiglitazone[J].BMJCaseRep,2009,DOI:10.1136/bcr.09.2008.0994.

    10. [10]

      InternationalDiabetesFederation.IDFdiabetesatlas[R].7thed.Brussels,Belgium:InternationalDiabetesFederation,2015.

    11. [11]

      LeungCC,LamTH,ChanWM,etal.Diabeticcontrolandriskoftuberculosis:acohortstudy[J].AmJEpidemiol,2008,167(12):1486-1494.

    12. [12]

      RuslamiR,AarnoutseRE,AlisjahbanaB,etal.Implicationsoftheglobalincreaseofdiabetesfortuberculosiscontrolandpatientcare[J].TropMedIntHealth,2010,15(11):1289-1299.

    13. [13]

      JeonCY,HarriesAD,BakerMA,etal.Bi-directionalscreeningfortuberculosisanddiabetes:asystematicReview[J].TropMedIntHealth,2010,15(11):1300-1314.

    14. [14]

      DoblerCC,FlackJR,MarksGB.Riskoftuberculosisamongpeoplewithdiabetesmellitus:anAustraliannationwidecohortstudy[J].BMJOpen,2012,2(1):e000666.

    15. [15]

      KumpatlaS,SekarA,AchantaS,etal.CharacteristicsofpatientswithdiabetesscreenedfortuberculosisinatertiarycarehospitalinSouthIndia[J].PublicHealthAction,2013,3Suppl1:S23-28.

    16. [16]

      AmareH,GelawA,AnagawB,etal.SmearpositivepulmonarytuberculosisamongdiabeticpatientsattheDessiereferralhospital,NortheastEthiopia[J].InfectDisPoverty,2013,2(1):6.

    17. [17]

      DooleyKE,ChaissonRE.Tuberculosisanddiabetesmellitus:convergenceoftwoepidemics[J].LancetInfectDis,2009,9(12):737-746.

    18. [18]

      PatelAK,RamiKC,GhanchiFD.RadiologicalpresentationofpatientsofpulmonarytuberculosiswithdiabetesMellitus[J].LungIndia,2011,28(1):70.

    19. [19]

      PalaciM,DietzeR,HadadDJ,etal.Cavitarydiseaseandquantitativesputumbacillaryloadincasesofpulmonarytuberculosis[J].JClinMicrobiol,2007,45(12):4064-4066.

    20. [20]

      ChalasaniN,FontanaRJ,BonkovskyHL,etal.Causes,clinicalfeatures,andoutcomesfromaprospectivestudyofdrug-inducedliverinjuryintheUnitedStates[J].Gastroenterology,2008,135(6):1924-1934.e4.

    21. [21]

      NijlandHM,RuslamiR,StalenhoefJE,etal.Exposuretorifampicinisstronglyreducedinpatientswithtuberculosisandtype2diabetes[J].ClinInfectDis,2006,43(7):848-854.

    22. [22]

      HeysellSK,MooreJL,KellerSJ,etal.Therapeuticdrugmonitoringforslowresponsetotuberculosistreatmentinastatecontrolprogram,Virginia,USA[J].EmergInfectDis,2010,16(10):1546-1553.

    23. [23]

      SinglaR,KhanN,Al-SharifN,etal.InfluenceofdiabetesonmanifestationsandtreatmentoutcomeofpulmonaryTBpatients[J].IntJTubercLungDis,2006,10(1):74-79.

    24. [24]

      AlisjahbanaB,SahiratmadjaE,NelwanEJ,etal.Theeffectoftype2diabetesmellitusonthepresentationandtreatmentresponseofpulmonarytuberculosis[J].ClinInfectDis,2007,45(4):428-435.

    25. [25]

      GlerM,UnsalE,DursunB,etal.Factorsinfluencingsputumsmearandcultureconversiontimeamongpatientswithnewcasepulmonarytuberculosis[J].IntJClinPract,2007,61(2):231-235.

    26. [26]

      RestrepoBI,Fisher-HochSP,SmithB,etal.Mycobacterialclearancefromsputumisdelayedduringthefirstphaseoftreatmentinpatientswithdiabetes[J].AmJTropMedHyg,2008,79(4):541-544.

    27. [27]

      ParkSW,ShinJW,KimJY,etal.TheeffectofdiabeticcontrolstatusontheclinicalfeaturesofpulmonaryTuberculosis[J].EurJClinMicrobiolInfectDis,2012,31(7):1305-1310.

    28. [28]

      ChangJT,DouHY,YenCL,etal.Effectoftype2diabetesmellitusontheclinicalseverityandtreatmentoutcomeinpatientswithpulmonarytuberculosis:apotentialroleintheemergenceofmultidrug-resistance[J].JFormosMedAssoc,2011,110(6):372-381.

    29. [29]

      ZhangQ,XiaoH,SugawaraI.TuberculosiscomplicatedbydiabetesmellitusatShanghaipulmonaryhospital,China[J].JpnJInfectDis,2009,62(5):390-391.

    30. [30]

      BalakrishnanS,VijayanS,NairS,etal.HighdiabetesprevalenceamongtuberculosiscasesinKerala,India[J].PLoSOne,2012,7(10):e46502.

    31. [31]

      KibirigeD,SsekitolekoR,MutebiE,etal.OvertdiabetesmellitusamongnewlydiagnosedUgandantuberculosispatients:acrosssectionalstudy[J].BMCInfectDis,2013,13(1):122.

    32. [32]

      VineyK,CavanaughJ,KieneneT,etal.TuberculosisanddiabetesmellitusintheRepublicofKiribati:acase-controlstudy[J].TropMedIntHealth,2015,20(5):650-657.

    33. [33]

      RizaAL,PearsonF,Ugarte-GilC,etal.Clinicalmanagementofconcurrentdiabetesandtuberculosisandtheimplicationsforpatientservices[J].LancetDiabetesEndocrinol,2014,2(9):740-753.

    34. [34]

      WorldHealthOrganization/InternationalUnionAgainstTuberculosisandLungDisease.Collaborativeframeworkforcareandcontroloftuberculosisanddiabetes[R].Geneva,Switzerland:WHO,2011.

    35. [35]

      VineyK,HoyD,RothA,etal.TheepidemiologyoftuberculosisinthePacific,2000to2013[J].WesternPacSurveillResponseJ,2015,6(3):59-67.

    36. [36]

      TheUnitedStatesCentersforDiseaseControlandPreventionandPacificIslandTBController'sAssociation.Pacificstandardsformanagementoftuberculosisanddiabetes,2013[EB/OL].[2016-06-07].http://www.spc.int/tb/images/stories/Pacific-TB-DM-Standards-V2.2.pdf.

    37. [37]

      WHO.TheendTBstrategy[R/OL].Geneva:WorldHealthOrganization,2015.[2016-06-07].http://www.who.int/tb/strategy.

    38. [38]

      KuangHB,ChenQC,LiHF,etal.Epidemiologicalfeaturesofpulmonarytuberculosis(PTB)patientscomplicatedwithdiabetesinGuangzhou[J].ChineseJournalofAntituberculosis,2010,32(8):458-461.(inChinese)邝浩斌,陈其琛,李惠芬,等.广州市城区肺结核合并糖尿病流行病学特征分析[J].中国防痨杂志,2010,32(8):458-461.

    39. [39]

      GuFH,LiuM,JiangSW,etal.EpidemiologicalfeaturesofpulmonarytuberculosisinpatientswithdiabetesmellitusintwodistrictsofBeijing[J].ChinesePreventiveMedicine,2013,14(4):246-250.(inChinese)顾芳慧,刘民,姜世闻,等.北京市两区糖尿病合并肺结核人群流行病学特征分析[J].中国预防医学杂志,2013,14(4):246-250.

    40. [40]

      WuZY,GuoJT,HuanY,etal.DiabetesmellitusinpatientswithpulmonarytuberculosisinanagingpopulationinShanghai,China:prevalence,clinicalcharacteristicsandoutcomes[J].JDiabetesComplications,2016,30(2):237-241.

    41. [41]

      LiL,LinY,MiFL,etal.ScreeningofpatientswithtuberculosisfordiabetesmellitusinChina[J].TropMedIntHealth,2012,17(10):1294-1301.

    42. [42]

      IndiaTuberculosis-DiabetesStudyGroup.ScreeningofpatientswithtuberculosisfordiabetesmellitusinIndia[J].TropMedIntHealth,2013,18(5):636-645.

    43. [43]

      LinY,LiL,MiFL,etal.ScreeningpatientswithdiabetesmellitusfortuberculosisinChina[J].TropMedIntHealth,2012,17(10):1302-1308.

    44. [44]

      IndiaDiabetesMellitus-TuberculosisStudyGroup.ScreeningofpatientswithdiabetesmellitusfortuberculosisinIndia[J].TropMedIntHealth,2013,18(5):646-654.

    45. [45]

      Castellanos-JoyaM,Delgado-SnchezG,Ferreyra-ReyesL,etal.ResultsoftheimplementationofapilotmodelforthebidirectionalscreeningandjointmanagementofpatientswithpulmonarytuberculosisanddiabetesmellitusinMexico[J].PLoSOne,2014,9(9):e106961.

    46. [46]

      HarriesAD,KumarAMV,SatyanarayanaS,etal.Diabetesmellitusandtuberculosis:programmaticmanagementissues[J].IntJTubercLungDis,2015,19(8):879-886.

    47. [47]

      SinghalA,JieL,KumarP,etal.Metforminasadjunctantituberculosistherapy[J].SciTranslMed,2014,6(263):263ra159.

    48. [48]

      LinY,HarriesAD.TuberculosisinfectioncontrolmeasuresindiabetesclinicsinChina:arapidassessmentof10hospitals[J].TropMedIntHealth,2015,20(9):1196-1200.

    49. [49]

      AllainTJ,vanOosterhoutJJ,DouglasGP,etal.ApplyinglessonslearntfromtheDOTStuberculosismodeltomonitoringandevaluatingpersonswithdiabetesmellitusinBlantyre,Malawi[J].TropMedIntHealth,2011,16(9):1077-1084.

    50. [50]

      MakaroffL,HegelundMH.TBanddiabetes:risks,managementandimprovingoutcomes[J/OL].DiabetesVoice,2016,61(1):26-29.[2016-06-07].http://www.idf.org/sites/default/files/attachments/DV-2016-1-Makaroff.pdf.

    51. [51]

      HarriesAD,KumarAMV,SatyanarayanaS,etal.AddressingdiabetesmellitusaspartofthestrategyforendingTB[J].TransRSocTropMedHyg,2016,110(3):173-179.

    52. [52]

      ChenH,LiZH,QuanL,etal.AwarenessofTBknowledgeandhealtheducationondiabetespatients[J].OccupationandHealth,2015,31(14):1921-1924.(inChinese)陈红,李智红,权力,等.糖尿病患者对结核病的知识知晓情况及其健康教育效果[J].职业与健康,2015,31(14):1921-1924.

    1. [1]

      孟德敬耿坤王秀云白云徐志鑫张倩 . 北京市昌平区成年人TG/HDL-C水平与糖尿病和糖尿病前期患病关系的研究. 疾病监测, 2016, 31(4): 329-333. DOI: 10.3784/j.issn.1003-9961.2016.04.016

    2. [2]

      蒋伏松侯旭宏杨丽萍李鸣孙庆毅陆慧娟贾伟平 . 云南省基诺族成年人糖尿病的患病率及其相关因素. 疾病监测, 2016, 31(7): 598-602. DOI: 10.3784/j.issn.1003-9961.2016.07.014

    3. [3]

      应倩陈坤 . 空间分析技术在结核病研究中的应用进展. 疾病监测, 2012, 27(4): 330-334. DOI: 10.3784/j.issn.1003-9961.2012.4.023

    4. [4]

      . 浙江省绍兴市60岁以上老年人肺结核流行病学分析. 疾病监测, 2015, 30(1): 46-49. DOI: 10.3784/j.issn.1003-9961.2015.01.013

    5. [5]

      龚震宇龚训良 . 全球结核病简报. 疾病监测, 2018, 33(4): 351-352. DOI: 10.3784/j.issn.1003-9961.2018.04.021

    6. [6]

      平措卓玛 . 2010年西藏自治区结核病监测资料分析. 疾病监测, 2013, 28(4): 269-271. DOI: 10.3784/j.issn.1003-9961.2013.4.006

    7. [7]

      徐彩红李涛彭孝旺刘慧慧张丽杰 . 2016年北京市城区结核病诊疗机构结核病感染控制现况调查. 疾病监测, 2017, 32(10/11): 824-827. DOI: 10.3784/j.issn.1003-9961.2017.10/11.010

    8. [8]

      王健周脉耕胡嘉马林茂邱林西 . 求和自回归移动平均模型在江西省结核病发病预测中的应用. 疾病监测, 2012, 27(6): 462-467. DOI: 10.3784/j.issn.1003-9961.2012.6.014

    9. [9]

      陈秀英梅少林雷永良陶毅王晓光凡鹏飞赖聪娟 . 浙江省丽水市结核病耐药性监测结果分析. 疾病监测, 2013, 28(7): 591-593. DOI: 10.3784/j.issn.1003-9961.2013.7.021

    10. [10]

      邢卫东王路钦王莉杨震张治国李涛杜昕张灿有成君赵飞马树波 . 2010-2017年北京市昌平区结核病登记率分析. 疾病监测, 2019, 34(5): 406-410. DOI: 10.3784/j.issn.1003-9961.2019.05.009

  • 20161028155406.pdf

  • 加载中
计量
  • PDF下载量:  58
  • 文章访问数:  794
  • HTML全文浏览量:  7
  • 引证文献数: 0
文章相关
  • 收稿日期:  2016-06-07
  • 刊出日期:  2016-10-20
通信作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章

在线交流